Plasminogen activator inhibitor Type-1 gene 4G/5G polymorphism is associated with hypertensive patients in the Turkish population

Genetic Testing and Molecular Biomarkers

Volumn 14, Issue 3, 2010, Pages 303-305

  Gunes, Hasan Veysi ^a   Cosan, Didem Turgut ^a   Ata, Necmi ^a   Birdane, Alparslan ^a   Ustuner, Mehmet Cengiz ^a   Dikmen, Miriş ^b   Bayram, Banu ^c   Degirmenci, Irfan ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^b ANADOLU UNIVERSITY   (Turkey)

^c MU ALPARSLAN UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AGAR GEL ELECTROPHORESIS; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PLASMINOGEN ACTIVATION; POLYMERASE CHAIN REACTION; TURKEY (REPUBLIC); ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK FACTOR; TURKEY;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; TURKEY;

EID: 77954897142     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2009.0199     Document Type: Article

References (17)

1. Aguayo AM, Fardella C (2009) Genetics of hypertensive syndrome. Horm Res 71:253-259.
2. Altun B, Arici M, Nergizoglu G, et al. (2005) Prevalence, awareness, treatment and control of hypertension in Turkey (the patent study) in 2003. J Hypertens 23:1817-1823.
3. Brown NJ, Murphey LJ, Srikuma N, et al. (2001) Interactive effect of PAI-1 4G/5G genotype and salt intake on PAI-1 antigen. Arterioscler Thromb Vasc Biol 21:1071-1077.
4. Cosan D, Kurt E, Kurt H, et al. (2009) Plasminogen activator inhibitor type-1 (PAI-1) gene 4G/5G polymorphism in patients with asthma in turkish adult patients with asthma. Genet Test Mol Biomark 13:543-546.
5. Ding J, Nicklas BJ, Fallin MD, et al. (2006) Plasminogen activator inhibitor type 1 gene polymorphisms and haplotypes are associated with plasma plasminogen activator inhibitor type 1 levels but not with myocardial infarction or stroke. Am Heart J 152:1109-1115.
6. Ergün UGO, Yildirim Y, Alparslan N (2002) Esansiyel Hi-pertansiyon Hastalarinda Sosyo-ekonomik Düzey Farkliliǧi ve. Ilaç Uyuncu. Türk Aile Hekimleri Dergisi 6:165-171.
7. Gerning NO, Mansfield MW, Stickland MH, et al. (1997) Plas-minogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography in patients characterized by coronary angiography. Arterioscler Thromb Vasc Biol 17:33-37.
8. Gunes H, Ata N, Degirmenci I, et al. (2004) Frequency of an-giotensin-converting enzyme gene polymorphism in Turkish hypertensive patients. Int J Clin Pract 58:838-843.
9. Izzo JL, Black HR (2003) Hypertension Primer, third edition. American Heart Association, Dallas, TX, pp 64-65.
10. Jeng J (2003) Association of PAI-1 gene promoter 4G/5G polymorphism with plasma PAI-1 activity in Chinese patients with and without hypertension. Am J Hypertens 16: 290-296.
11. Kucukarabaci B, Gunes HV, Ozdemir G, et al. (2008) Investigation of association between plasminogen activator inhibitor type-1 (PAI-1) gene 4G/5G polymorphism frequency and plasma PAI-1 enzyme activity in patients with acute stroke. Genet Test 12:443-451.
12. Lijnen HR (2005) Pleiotropic functions of plasminogen activator inhibitor-1. J Thromb Haemost 3:35-45.
13. Martinez CMJ, Gonzales SJL, Zabena C, et al. (2007) Is the plasminogen activator inhibitor-1 gene a candidate gene predisposing to hypertension? Results from a population-based study in Spain. J Hypertens 25:773-777.
14. Su S, Chen S, Zhao J, et al. (2006) Plasminogen activator inhibitor-1 gene: selection of tagging single nucleotide polymorphisms and association with coronary heart disease. Arterioscler Thromb Vasc Biol 26:948-954.
15. Wiklund P, Nilsson L, Ardnor SN, et al. (2005) Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts. Stroke 36:1661-1665.
16. Yalçn BM, Fiahn EM (2002) Birinci Basamakta Esansiyel Hi-pertansiyona Yaklaş?m. Trakya Ü niversitesi Tip Fakü ltesi Dergisi 19:162-170.
17. Yilmaz E, Akar E, Akar N (2004) Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in turkish deep vein thromboembolic patients with and without prothrombin. Turk J Haematol 21:83-86.